Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
X-Chem and Sironax Begin Neurodegenerative Disease Drug Discovery Research Partnership
Details :
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
May 01, 2023
Lead Product(s) : SIR0365
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I/ Phase II
Sponsor : Gaorong Capital
Deal Size : $200.0 million
Deal Type : Series B Financing
Sironax Announces Closing of $200 Million Series B Financing
Details :
Product Name : SIR0365
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
February 08, 2022
Lead Product(s) : SIR0365
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I/ Phase II
Sponsor : Gaorong Capital
Deal Size : $200.0 million
Deal Type : Series B Financing